Literature DB >> 16724371

Therapies for axial disease in psoriatic arthritis. A systematic review.

Peter Nash1.   

Abstract

Prevalence rates for axial involvement in psoriatic arthritis (PsA) vary from 40% to 74% depending upon criteria for diagnosis. In the absence of trial evidence to assess axial involvement in PsA, the GRAPPA group, by consensus, has suggested that outcome measures and therapies for axial disease in ankylosing spondylitis (AS) be used. This systematic review addresses the management of axial disease in PsA, and provides treatment recommendations based on the AS literature.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16724371

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


  13 in total

Review 1.  Treatment algorithms for early psoriatic arthritis: do they depend on disease phenotype?

Authors:  William Tillett; Neil McHugh
Journal:  Curr Rheumatol Rep       Date:  2012-08       Impact factor: 4.592

Review 2.  Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007.

Authors:  D E Furst; F C Breedveld; J R Kalden; J S Smolen; G R Burmester; J Sieper; P Emery; E C Keystone; M H Schiff; P Mease; P L C M van Riel; R Fleischmann; M H Weisman; M E Weinblatt
Journal:  Ann Rheum Dis       Date:  2007-11       Impact factor: 19.103

Review 3.  The treatment of psoriatic arthritis and inflammatory spondylitis.

Authors:  Hernan Castro-Rueda; Arthur Kavanaugh
Journal:  Curr Pain Headache Rep       Date:  2008-12

Review 4.  [Evidence-based physiotherapeutic strategies for musculoskeletal pain].

Authors:  U Lange; U Müller-Ladner
Journal:  Z Rheumatol       Date:  2008-12       Impact factor: 1.372

5.  Assessment and treatment of psoriatic spondylitis.

Authors:  Peter Nash
Journal:  Curr Rheumatol Rep       Date:  2009-08       Impact factor: 4.592

6.  [Treatment recommendations for psoriatic arthritis].

Authors:  W-H Boehncke
Journal:  Z Rheumatol       Date:  2009-12       Impact factor: 1.372

7.  [Psoriatric arthritis - a permanent challenge for rheumatologists and patients: part 2: imaging diagnostics, classification and therapy].

Authors:  S Finzel; M Englbrecht
Journal:  Z Rheumatol       Date:  2011-11       Impact factor: 1.372

Review 8.  Axial disease in psoriatic arthritis.

Authors:  Dafna D Gladman
Journal:  Curr Rheumatol Rep       Date:  2007-12       Impact factor: 4.592

Review 9.  Psoriatic arthritis: pharmacotherapy update.

Authors:  Philip J Mease
Journal:  Curr Rheumatol Rep       Date:  2010-08       Impact factor: 4.592

Review 10.  Treatment recommendations for psoriatic arthritis.

Authors:  C T Ritchlin; A Kavanaugh; D D Gladman; P J Mease; P Helliwell; W-H Boehncke; K de Vlam; D Fiorentino; O Fitzgerald; A B Gottlieb; N J McHugh; P Nash; A A Qureshi; E R Soriano; W J Taylor
Journal:  Ann Rheum Dis       Date:  2008-10-24       Impact factor: 19.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.